SBIR-STTR Award

Peptide For Gentle Purification Of Biotinylated Protein
Award last edited on: 4/17/02

Sponsored Program
SBIR
Awarding Agency
NIH : NIGMS
Total Award Amount
$99,750
Award Phase
1
Solicitation Topic Code
-----

Principal Investigator
Ronald E Gill

Company Information

Avidity LLC

1899 Gaylord Street
Denver, CO 80206
   (303) 320-6063
   info@avidity.com
   www.avidity.com
Location: Single
Congr. District: 01
County: Denver

Phase I

Contract Number: 1R43GM062040-01A1
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
2001
Phase I Amount
$99,750
Affinity tag technology has become increasingly important for immobilizing proteins for high-throughput screening, for generating protein arrays, and for simplifying protein purification. There is a pressing need for economical and technically simple technologies to immobilize or purify proteins. None of the existing molecular tags used for affinity purification is ideal for both purification and immobilization of proteins. The avidin-biotin complex has the highest affinity interaction known in nature, and this characteristic has made the avidin-biotin technology the gold standard for immobilizing proteins. A recent advance in this technology has been the development of biotin-accepting peptides (AviTag) that can be fused to proteins and exploited for applications requiring protein immobilization such as high-throughput screening, generating protein arrays, staining and sorting cells, and analysis of protein-protein interactions using surface plasmon resonance. Unfortunately, current non-denaturing methods of purifying biotinylated proteins are relatively expensive and technically problematic. In the proposed study, we will use directed evolution, a powerful technique for identifying highly specific peptide ligands, to create a new, low cost, highly selective affinity purification modality to complement our existing technology for immobilization of biotinylated protein.

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----